Does Medicare cover Revlimid in Oregon?

What Revlimid is used for

Revlimid is a capsule taken by mouth. Its FDA label covers multiple myeloma (with dexamethasone, and as maintenance after a stem cell transplant), certain myelodysplastic syndromes, mantle cell lymphoma after other treatments, and previously treated follicular and marginal zone lymphoma.

This page explains Medicare coverage only. Questions about whether Revlimid is right for you belong with your prescriber.

Which part of Medicare covers Revlimid

Revlimid is an oral capsule with no injectable form, so it's a Part D drug. Lenalidomide can only be prescribed and dispensed through FDA's lenalidomide REMS safety program, which certifies prescribers and pharmacies. In practice, that means your plan will route the prescription to a certified, usually specialty, pharmacy in its network.

Is Revlimid on Medicare's negotiated-price list?

Revlimid is not among the drugs CMS has selected for the Medicare Drug Price Negotiation Program so far (the 10 drugs with negotiated prices for 2026, the 15 for 2027 and the 15 selected in January 2026 for 2028).

Generics and biosimilars

FDA approved the first generic lenalidomide in October 2021, and more generic makers since; generics have been sold in the U.S. since 2022. A plan may put generic lenalidomide on its formulary and require an exception for the brand. Extra Help copays are lower for generics.

Revlimid alongside other myeloma treatment

Revlimid is often one piece of a combination. Infused or injected myeloma drugs given at a cancer center are usually covered by Part B, while Revlimid and other pills are covered by Part D. That split means two sets of costs: Part D costs count toward the $2,400 cap, while Part B costs count toward Medigap or a Medicare Advantage plan's yearly limit. When you compare plans, check both the oncology network and the Part D coverage.

What you pay for Revlimid in 2027: the out-of-pocket cap

Your cost for Revlimid depends on your plan: its deductible, the tier it puts the drug on, and whether you use a preferred pharmacy. This site doesn't list plan costs; your plan's formulary and Evidence of Coverage do. What Medicare sets for everyone with Part D is the limit:

• 2027 out-of-pocket cap: $2,400 (it was $2,100 in 2026). Once what you pay for covered Part D drugs (deductible, copays and coinsurance) reaches the cap, you pay nothing more for covered Part D drugs for the rest of 2027.
• The maximum Part D deductible for 2027 is $700. No plan can set a higher deductible.
• Only covered drugs count. If your plan doesn't cover Revlimid and you pay cash, or you use a discount card instead of your plan, that spending doesn't count toward the cap.

Spreading the cost: the Medicare Prescription Payment Plan

The Medicare Prescription Payment Plan lets you pay your Part D drug costs in monthly bills from your plan across the calendar year instead of all at once at the pharmacy. Medicare.gov says there's no cost to participate, but it doesn't lower your drug costs; it only changes when you pay. It helps most when costs are high early in the year. To join, call your plan or use its website. More in What is the Medicare Prescription Payment Plan?

Extra Help with Revlimid

Extra Help (the Low-Income Subsidy) is a federal program that lowers Part D premiums, deductibles and copays. For 2027, CMS caps Extra Help copays for covered drugs at $5.80 for a generic and $14.40 for a brand-name drug, and some people with full Medicaid pay less. You get Extra Help automatically if you have OHP (Medicaid), a Medicare Savings Program or SSI; otherwise apply through Social Security at 1-800-772-1213 or ssa.gov/extrahelp. See Extra Help in Oregon.

Getting Revlimid covered in Oregon

Oregon and Washington share Part D region 30, so standalone Part D plans are offered region-wide. For 2027, Oregon has 8 standalone Part D plans from 4 companies, plus Medicare Advantage plans with drug coverage in most counties (61 open to everyone statewide). Each plan has its own formulary, so one plan's coverage of Revlimid tells you nothing about another's.

Where you live in Oregon changes your choices. CMS data show no Medicare Advantage plan open to everyone in Grant, Harney, Lake, Umatilla or Union counties for 2027 (only employer group plans), and only a special needs plan in Curry County. If you live there, coverage for Revlimid usually comes from a standalone Part D plan alongside Original Medicare, unless you have employer or other drug coverage. Check your county's numbers on Oregon counties.

If you have both Medicare and OHP, OHP doesn't pay for drugs that Part D covers. The Oregon Health Authority calls this "OHP with Limited Drug": you need a Part D plan (or a Medicare Advantage plan with drug coverage) for Revlimid, and you qualify for Extra Help automatically. See OHP and Medicare.

How to check whether a plan covers Revlimid

1. Write down the exact drug. Name, strength and how often you take it. A plan can cover one form of Revlimid and not another.
2. Look it up in each plan's formulary. Enter your drugs and ZIP code on PlanMatch or Medicare.gov's Plan Finder to see which plans list Revlimid and any rules.
3. Read the rules next to the drug. Prior authorization, step therapy or quantity limits mean your prescriber may need to send the plan information before it pays.
4. Check your 2027 notice. Your plan's Annual Notice of Change says whether Revlimid stays on the formulary next year. Open Enrollment runs October 15 to December 7, 2026, for coverage starting January 1, 2027.
5. Get help if you want it. You can request a call from a licensed insurance agent, who can compare plans from the companies they work with, or call 1-800-MEDICARE (1-800-633-4227, TTY 1-877-486-2048) for information on all of your options.

If your plan doesn't cover Revlimid, you or your prescriber can ask for a coverage determination or a formulary exception. Once the plan has your prescriber's supporting statement, it generally must decide within 72 hours, or 24 hours if your prescriber says waiting could seriously harm your health. New members can usually get a one-time transition supply of a drug they were already taking while they ask for an exception or switch. See How do I appeal a Medicare denial in Oregon?

Sources

• National Library of Medicine — DailyMed: Revlimid prescribing information (FDA label)
• Medicare.gov — Drug coverage (Part D)
• Medicare.gov — Prescription drugs (outpatient) under Part B
• FDA — Orange Book: approved drug products and generic equivalents
• eCFR — 42 CFR 423.120 (formularies, protected classes and transition fills)
• CMS — CY 2027 Rate Announcement (2027 Part D out-of-pocket threshold and Extra Help copays)
• Medicare.gov — Medicare Prescription Payment Plan
• Social Security — Extra Help with Medicare prescription drug plan costs
• CMS — Selected drugs and negotiated prices (Medicare Drug Price Negotiation Program)
• CMS — Part D plan files record layout (PDP Region 30: Oregon, Washington)
• Oregon Health Authority — OHP and Medicare

Frequently asked questions

Medicare in your Oregon county

Plans, local agents and help, county by county: Multnomah · Washington · Clackamas · Lane · Marion · Jackson · Deschutes · Linn · Douglas · Yamhill · Benton · Polk · Josephine · Umatilla · Klamath · Coos · Columbia · Lincoln · Clatsop · Malheur · All 36 counties →